Technology

How do we secure a ‘second wave of innovation’ post-COVID-19?

Lyn Whitfield, content director at Highland Marketing, updates us on the outcomes of its advisory board’s June meeting as it discussed the impact of the Coronavirus outbreak on the deployment of healthtech in the NHS. At its June meeting, Highland Marketing’s advisors discussed some of the challenges that face overseas companies, start-ups and scale-ups in accessing the healthtech market; and how they might be overcome so they can play their part in helping the NHS to ‘reset, not just recover’ after the coronavirus outbreak. The Highland Marketing advisory board has been discussing the impact of the coronavirus outbreak on the deployment of health tech in the NHS. At its March meeting, which took place just after UK prime minister Boris Johnson instructed people to “stay at home”, members ...

Why continuous glucose monitoring will shape the future for diabetics

Parvez Khodabocus, director, group purchasing organisation at HealthTrust Europe, explores the technology which is available to diabetics, and examines some of the key developments that have been made in this area of medical innovation over the past few years. Diabetes is a condition that affects roughly 415 million people across the world. Type 1 diabetes, the lesson common type of diabetes, is when your body attacks the cells in your pancreas which means it cannot make any insulin. Type 2 diabetes, on the other hand, is when your body is unable to make enough insulin or the insulin you do make does not work properly. Although diabetics can live healthy, happy and productive lives, a crucial part of managing the illness is ensuring that blood sugar levels are kept under control. To do thi...

Medilink EM webinar to discuss medtech and neurological conditions

Medilink East Midlands will be running a webinar on opportunities in medtech when it comes to technologies to help those with long-term neurological conditions on Thursday 9th July. People living with conditions such as; MND, MS, Parkinson’s Disease, are reported to have the lowest health-related quality of life of any long-term condition, with the numbers of people affected continuing to rise. As society and healthcare systems respond and adapt to the impact of the COVID-19 pandemic, this webinar is an opportunity for businesses to: Understand the key challenges affecting patients & the heath and care system Learn about the market for technology solutions within new models of care and self-management  Connect with collaborative networks to catalyse & advance p...

How ventilator companies can keep up with demand

Cory Levins, director of business development, Air Sea Containers, offers his advice to ventilator companies with the aim of helping them cope during the pandemic.  As the COVID-19 global pandemic spreads throughout the world, ventilator companies have tried to ramp up their production in an attempt to help supply countries with this life-saving device. Coronavirus has been found to attack patient’s respiratory systems, making it difficult to breathe, and for those who already suffer from respiratory problems, this symptom could be life-threatening. Here are some ways companies can manage the uptick in demand. The ventilator shortage Ventilators are devices that help patients breathe, and there are a few different types that could be useful during this pandemic. Non-invasive ventilato...

Endoscope in development for early bladder cancer detection

A European photonics research team is developing a new endoscope to scan for the early signs of bladder cancer. Using multi-wavelength lasers, the scanner will provide non-invasive and detailed information to determine what stage and grade that a tumour has reached and provide early diagnosis. Bladder cancer (BLC) is the sixth most commonly occurring cancer in men and the 17th most commonly occurring cancer in women. According to the World Cancer Research fund, there were nearly 550,000 new cases of bladder cancer worldwide in 2018. Cancers that form in the bladder are difficult to spot in their early stages and are often missed when using white light. At present, clinicians struggle to create accurate, detailed images inside the bladder because light cannot penetrate deep into t...

Funding totalling £4.5m raised for start-ups to help combat COVID-19

At a time when investment and funding prospects for the healthtech and life science industry have dried up, and some investors have reneged on deals due to COVID-19: LiveSmart, Knok Healthcare, Log My Care, Firza, and MediShout are among the start-ups to receive funding. Patients could benefit from these innovations, made possible by investments from RYSE Asset Management and other investors. These companies have raised a total of £4.5 million. Busy clinical working environments are faced with logistical issues that can create delays and increase the cost of care delivery. This has been particularly apparent during the pandemic where efficient redeployment of resources is paramount. Virtual consultations, workforce optimisation solutions for primary healthcare providers, platforms for digi...

New minimally invasive treatment for fibroids launches

Gynesonics, a medtech company specialising in women’s health, has launched the Sonata System – a transcervical fibroid ablation system that uses radiofrequency (RF) energy for the treatment of symptomatic uterine fibroids. Sonata integrates ultrasound and radiofrequency into a single, handheld delivery system to locate and target individual fibroids. Gynesonics claims it is a safe alternative to more invasive treatment options such as myomectomies and hysterectomies.Approximately 600,000 women undergo surgical interventions for fibroids in Europe and the US and a recent survey revealed that women with uterine fibroids, on average, delay seeking treatment for 3.6 years, with 79% wanting to avoid invasive surgery that can require lengthy recoveries. Hysterectomies and myomectomies are the mo...

How a packaging firm’s expertise informed its COVID-19 response

Riverside Medical Packaging’s expertise in the medical industry has seen it adapt quickly to help design and supply face shields in the fight against COVID-19. Set up by David Shaw 40 years ago, Riverside’s 6,000 sq metre manufacturing facility in Derby has been tailor-made specifically for the manufacture of medical packaging and packing of medical devices. Over the past six years, the company has set up two further divisions, Shawpak and (AMD) Aseptic Medical Devices. As routine surgical procedures were curtailed due to the pandemic, Riverside adapted its business model and became involved in the cleaning of air pathway components for a UK manufacturer involved in the Ventilator Challenge set by the government. Matt Roe, managing director at Riverside Medical, said: “Our expe...

Women’s health and digital therapeutics at centre of EIT Health Hackathon

The EIT Health Wild Card Hackathon has begun online with 45 innovators coming together to find new solutions in women’s health and digital therapeutics. Now in its third year, the EIT Health Wild Card programme builds life science companies to break new ground in health by challenging the status quo in areas of high unmet need. Beginning with two challenges set by EIT Health, the annual Wild Card programme invites innovators from across Europe to respond with their ideas. Successful applicants start their journey with a hackathon; putting them through their paces on everything from team formation, critical thinking, business model development and pitching. Finally, participants pitch their solution to a panel of industry leaders to secure a spot in the finals, at which point they pitch for...

How technology is opening the doors to a new kind of normal

Tracey Francis, managing director, Capita Healthcare, looks at the future of healthcare post-pandemic, and how the benefits of technology are being realised. The COVID-19 pandemic has turned the use of healthcare technology on its head. GPs across the UK are now using telephone or video consultations to meet with their patients and maintain social distancing guidelines. In some areas, up to 95% of patient consultations are now being carried out online or over the phone. Online consultations and the use of online triage solutions have not only helped keep people safe and ease the demand on frontline services during the pandemic, but have also increased the accessibility of services to patients by speeding up the streaming process, identifying sick patients earlier, reducing waiting times an...

Prosthetic arm launched with direct to consumer approach

Unlimited Tomorrow, a medical device company manufacturing prosthetic limbs, has launched TrueLimb, a prosthetic arm that is available through a completely remote process which amputees can initiate online. TrueLimb costs 80% less than traditional prosthetics. It is a functional and durable robotic upper limb prosthesis with multi-grip capability and individual finger control allowing for natural movement and positioning. TrueLimb is uniquely designed for each user and personalised to their skin tone, weight, shape, and size. This level of customisation is made possible using Unlimited Tomorrow’s proprietary software, intelligent design, and advanced manufacturing techniques. Using 3D printing technology, Unlimited Tomorrow delivers a remote, all-in-one solution. This gives individual...

Home-use Coronavirus antibody test reaches ‘major milestone’

BBI Solutions, part of the UK-Rapid Test Consortium (UK-RTC), has reached a ‘major milestone’ in the development of a COVID-19 lateral flow antibody test. The UK-RTC has announced that it has reached design freeze for the test, which has been designed for people to use in their own homes. The ‘major milestone’ means that the test meets the required performance characteristics and the production specifications of the assay, or laboratory procedure, have now been set. The next stage will see the scale-up of processes this month, in readiness for manufacture. Tests carried out prior to reaching the design freeze stage reported a 98.6% accuracy. The UK-RTC is continuing to work with the regulatory authorities to ensure approval of the test as quickly as possible. As part of its role within the...